Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELEGANT: EC vs TC in Early Breast Cancer
NCT02549677Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Oct 2015
- Primary completion
- Mar 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of epirubicin in breast cancer, sponsored by Ruijin Hospital. Started Oct 2015; status: completed.
02
Drugs
epirubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02549677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02549677.